Clinical trial
Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)
NCT00344227 · University of Miami, Other · Completed
Key facts
| NCT number | NCT00344227 |
|---|---|
| Title | Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study) |
| Official title | Prospective Optical Coherence Tomography (OCT) Imaging of Patients With Neovascular Age-Related Macular Degeneration (AMD) Treated With Intra-Ocular Lucentis™ (Ranibizumab): PrONTO Study |
| Lead sponsor | University of Miami, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neovascular Age-Related Macular Degeneration |
| Intervention type | Drug |
| Interventions | Lucentis (Ranibizumab) |
| Enrollment | 40 |
| Start date | Aug 1, 2004 |
| Completion | Apr 1, 2007 |
| First posted | Jun 26, 2006 |
| Last update posted | Jun 26, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: